1. Home
  2. CALC vs RDI Comparison

CALC vs RDI Comparison

Compare CALC & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • RDI
  • Stock Information
  • Founded
  • CALC 2011
  • RDI 1937
  • Country
  • CALC United States
  • RDI United States
  • Employees
  • CALC N/A
  • RDI N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • RDI Movies/Entertainment
  • Sector
  • CALC Health Care
  • RDI Consumer Discretionary
  • Exchange
  • CALC Nasdaq
  • RDI Nasdaq
  • Market Cap
  • CALC 36.0M
  • RDI 35.2M
  • IPO Year
  • CALC N/A
  • RDI N/A
  • Fundamental
  • Price
  • CALC $2.35
  • RDI $1.40
  • Analyst Decision
  • CALC Strong Buy
  • RDI Hold
  • Analyst Count
  • CALC 5
  • RDI 1
  • Target Price
  • CALC $18.20
  • RDI $2.40
  • AVG Volume (30 Days)
  • CALC 31.5K
  • RDI 68.0K
  • Earning Date
  • CALC 03-27-2025
  • RDI 03-31-2025
  • Dividend Yield
  • CALC N/A
  • RDI N/A
  • EPS Growth
  • CALC N/A
  • RDI N/A
  • EPS
  • CALC N/A
  • RDI N/A
  • Revenue
  • CALC N/A
  • RDI $197,270,000.00
  • Revenue This Year
  • CALC N/A
  • RDI N/A
  • Revenue Next Year
  • CALC N/A
  • RDI $18.29
  • P/E Ratio
  • CALC N/A
  • RDI N/A
  • Revenue Growth
  • CALC N/A
  • RDI N/A
  • 52 Week Low
  • CALC $2.05
  • RDI $1.22
  • 52 Week High
  • CALC $6.27
  • RDI $1.97
  • Technical
  • Relative Strength Index (RSI)
  • CALC 35.06
  • RDI 38.79
  • Support Level
  • CALC $2.36
  • RDI $1.54
  • Resistance Level
  • CALC $2.66
  • RDI $1.62
  • Average True Range (ATR)
  • CALC 0.24
  • RDI 0.10
  • MACD
  • CALC -0.02
  • RDI -0.02
  • Stochastic Oscillator
  • CALC 4.13
  • RDI 11.63

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.

Share on Social Networks: